View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Functional and biomarker assays for the exploration of every angle of the complement system
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Let us develop a custom iLite® cell line tailored to your needs.
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
Regulatory changes can often seem daunting, but they are essential for ensuring the highest standards of safety and performance. The IVDR brings significant benefits to clinical practices, and understanding these benefits is crucial for making informed decisions.
The IVDR introduces more rigorous requirements for clinical evidence, post-market surveillance, and transparency. For purchasers, tenders, procurement professionals, physicians, and lab directors, this means greater confidence in the reliability and safety of diagnostic tools.
At Svar Life Science, we are committed to achieving IVDR compliance to provide you with the best possible solutions. We aim to turn these changes into opportunities and outline what is required for the future. By choosing Svar Life Science, you are partnering with a company that prioritizes regulatory excellence and long-term support.